EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Applications of nanomaterials in anti‐VEGF treatment for ophthalmic diseases

Lu Teng, Yabin Sun, Siying Teng, Peng Hui

Journal of Biomedical Materials Research Part A · 2024

DOI: 10.1002/jbm.a.37626 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Biomedical Materials Research Part A, 2024. Verfasst von Lu Teng und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Bethune Hospital of Jilin University, Jilin, China. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Diabetic Retinopathy, Macular Degeneration. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: Natural Science Foundation of Jilin Province, Jilin University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis has been determined to be essential in the occurrence and metastasis of diabetic retinopathy (DR), age‐related macular degeneration (AMD), retinal vein occlusion (RVO), choroidal neovascularization (CNV), retinopathy of prematurity (ROP), tumor, etc. However, the clinical use of anti‐vascular endothelial growth factors (VEGF) drugs is currently limited due to its high cost, potential side effects, and need for repeated injections. In recent years, nanotechnology has shown promising results in inhibiting neovascularization and reducing reactive oxygen species (ROS) or inflammatory factors. Some nanomaterials can also act as vehicles for drug delivery, such as lipid nanoparticles and PLGA. The process of angiogenesis and its molecular mechanism are discussed in this article. At the same time, this study aims to systematically review the research progress of nanotechnology and offer more treatment options for neovascularization‐related diseases in clinical ophthalmology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Choroidal NeovascularizationDiabetic RetinopathyMacular DegenerationHumansInfant, NewbornAngiogenesis InhibitorsInjectionsVascular Endothelial Growth Factor A

Stichwörter der Autor:innen

VEGFangiogenesismolecular mechanismnanomaterialsophthalmology

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • The First Bethune Hospital of Jilin University, Jilin, China.

Förderung

  • Natural Science Foundation of Jilin Province
  • Jilin University

Zitieren

APA

Teng, L., Sun, Y., Teng, S., & Hui, P. (2024). Applications of nanomaterials in anti‐VEGF treatment for ophthalmic diseases. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37626

Vancouver

Teng L, Sun Y, Teng S, Hui P. Applications of nanomaterials in anti‐VEGF treatment for ophthalmic diseases. Journal of Biomedical Materials Research Part A. 2024. doi:10.1002/jbm.a.37626

BibTeX
@article{Teng2024,
  author = {Teng, Lu and Sun, Yabin and Teng, Siying and Hui, Peng},
  title = {Applications of nanomaterials in anti‐VEGF treatment for ophthalmic diseases},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2024},
  doi = {10.1002/jbm.a.37626}
}
Kostenlos starten →